- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Clinical research cut 87% at peak of pandemic | ||
| Di | WHF partners with AstraZeneca to reduce burden of CV disease | ||
| Di | AstraZeneca kicks off PhI trial of potential COVID-19 therapy | ||
| Di | First coronavirus re-infection reported in Hong Kong | ||
| Mo | Gov unveils fund for follow-on care | ||
| Mo | AstraZeneca partners with RenalytixAI in chronic disease pact | ||
| Mo | Novartis' melanoma combo fails in PhIII | ||
| Mo | EU nod for Vertex CF therapy Kaftrio | ||
| Fr | Patient Partnership Index virtual conference to take place October 7 | ||
| Fr | US expand use of Janssen's Darzalex | ||
| Fr | J&J to acquire Momenta for $6.5 billion | ||
| Fr | CMOs urge trusts to continue recruiting for RECOVERY trial | ||
| Do | Roche and Regeneron link over antiviral antibody combo | ||
| Do | First trial participant gets GSK's 5-in-1 meningitis jab | ||
| Do | Skin cancer deaths rocket 70% since the 1970s | ||
| Do | Survey reveals Britains welcome shift to virtual healthcare | ||
| 19.08. | Verona progresses PhII trial of COPD inhaler | ||
| 19.08. | Priority review for Imfinzi's less-frequent dosing regimen | ||
| 19.08. | Gov announces expansion of UK's ONS COVID-19 survey | ||
| 19.08. | Hancock confirms replacement of Public Health England | ||
| 18.08. | Roche's Enspryng approved for Neuromyelitis Optica Spectrum Disorder | ||
| 18.08. | EU regulators to review Evrysdi for SMA | ||
| 18.08. | Study confirms link between SABA inhalers and asthma exacerbations | ||
| 18.08. | Doctors express concern over clearing NHS bottleneck | ||
| 17.08. | Sanofi buys Principia Biopharma |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
